Cyclooxygenase-2 (COX-2) in multiple myeloma: Prognostic marker or therapeutic target?

被引:0
|
作者
Owen, Roger G.
Fan, Im
O'Connor, Sheila J. M.
Davies, Faith E.
Rollett, Rebecca A.
Child, J. Anthony
Rawstron, Andy C.
机构
[1] Leeds Teaching Hosp NHS Trust, HMDS Lab, Leeds, W Yorkshire, England
[2] Inst Canc Res, Sect HaematoOncol, Sutton, Surrey, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5051
引用
收藏
页码:352B / 352B
页数:1
相关论文
共 50 条
  • [1] Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?
    Owen, Roger G.
    Fan, Im
    O'Connor, Sheila J. M.
    Rollett, Rebecca A.
    Child, J. Anthony
    Davies, Faith E.
    Rawstron, Andy C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 163 - 164
  • [3] Clinical significance of cyclooxygenase-2 (COX-2) in multiple myeloma
    Trojan, A
    Tinguely, M
    Vallet, S
    Seifert, B
    Jenni, B
    Zippelius, A
    Witzens-Harig, M
    Mechtersheimer, G
    Ho, AD
    Goldschmidt, H
    Jäger, D
    Boccadoro, M
    Ladetto, M
    SWISS MEDICAL WEEKLY, 2006, 136 (25-26) : 400 - 403
  • [4] Cyclooxygenase-2 (COX-2) - A therapeutic target in liver cancer?
    Breinig, Marco
    Schirmacher, Peter
    Kern, Michael Andre
    CURRENT PHARMACEUTICAL DESIGN, 2007, 13 (32) : 3305 - 3315
  • [5] Increased cyclooxygenase-2 (COX-2) expression in acute myocardial infarction: Therapeutic target of a selective COX-2 inhibitor
    Saito, T
    Rodger, IW
    Hu, F
    Tayara, L
    Giaid, A
    CIRCULATION, 2000, 102 (18) : 271 - 271
  • [6] Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
    Gallego, G. Aparicio
    Prado, S. Diaz
    Fonseca, P. Jimenez
    Campelo, R. Garcia
    Espinosa, J. Cassinello
    Aparicio, L. M. Anton
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (11): : 694 - 702
  • [7] Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
    G. Aparicio Gallego
    S. Díaz Prado
    P. Jiménez Fonseca
    R. García Campelo
    J. Cassinello Espinosa
    L. M. Antón Aparicio
    Clinical and Translational Oncology, 2007, 9 : 694 - 702
  • [8] Cyclooxygenase-2 in multiple myeloma: prognostic factor of therapeutic target? - Response to Owen et al
    Kast, R. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (01) : 165 - 165
  • [9] Intratumoral expression of cyclooxygenase-2 (COX-2) is a negative prognostic marker for patients with cutaneous melanoma
    Kuzbicki, Lukasz
    Lange, Dariusz
    Stanek-Widera, Agata
    Chwirot, Barbara W.
    MELANOMA RESEARCH, 2016, 26 (05) : 448 - 456
  • [10] Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome
    Ladetto, M
    Vallet, S
    Trojan, A
    Dell'Aquila, M
    Monitillo, L
    Rosato, R
    Santo, L
    Drandi, D
    Bertola, A
    Falco, P
    Cavallo, F
    Ricca, I
    De Marco, F
    Mantoan, B
    Bode-Lesniewska, B
    Pagliano, G
    Francese, R
    Rocci, A
    Astolfi, M
    Compagno, M
    Mariani, S
    Godio, L
    Marino, L
    Ruggeri, M
    Omedè, P
    Palumbo, A
    Boccadoro, M
    BLOOD, 2005, 105 (12) : 4784 - 4791